S15-434 Agents to induce immunogenicity and improve efficacy of anti-cancer therapeutics Researchers at Stanford have developed agents to enhance the therapeutic efficacy of a variety of anti-cancer therapeutics. Cell loss by apoptosis occurs in normal development and in tumor environments. Irving Weissman Aaron Ring Daniel Corey Melissa McCracken